Mitochondrial genome analysis in biofluids for early cancer detection and monitoring

Bibliography

• Leon SA, Shapiro B, Sklaroff DM, et al. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 1977;37:646-50
   PubMed Web of Science ®Google Scholar
• Sidransky D, Von Eschenbach A, Tsai YC, et al. Identification of p53 gene mutations in bladder cancers and urine samples. Science 1991;252:706-9
   PubMed Web of Science ®Google Scholar
• Gormally E, Caboux E, Vineis P, et al. Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance. Mutat Res 2007;635:105-17
   PubMed Web of Science ®Google Scholar
• Pathak AK, Bhutani M, Kumar S, et al. Circulating cell-free DNA in plasma/serum of lung cancer patients as a potential screening and prognostic tool. Clin Chem 2006;52:1833-42
   PubMed Web of Science ®Google Scholar
• Muller H, Brenner H. Urine markers as possible tools for prostate cancer screening: review of performance characteristics and practicality. Clin Chem 2006;52:562-73
   PubMed Web of Science ®Google Scholar
• Belinsky SA, Klinge DM, Dekker JD, et al. Gene promoter methylation in plasma and sputum increases with lung cancer risk. Clin Cancer Res 2005;11:6505-11
   PubMed Web of Science ®Google Scholar
• Jahr S, Hentze H, Englisch S, et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 2001;61:1659-65
   PubMed Web of Science ®Google Scholar
• Hu YC, Sidransky D, Ahrendt SA. Molecular detection approaches for smoking associated tumors. Oncogene 2002;21:7289-97
   PubMed Web of Science ®Google Scholar
• Ahrendt SA, Chow JT, Xu LH, et al. Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer. J Natl Cancer Inst 1999;91:332-9
   PubMed Web of Science ®Google Scholar
• Mills NE, Fishman CL, Scholes J, et al. Detection of K-ras oncogene mutations in bronchoalveolar lavage fluid for lung cancer diagnosis. J Natl Cancer Inst 1995;87:1056-60
   PubMed Web of Science ®Google Scholar
• Cairns P, Esteller M, Herman JG, et al. Molecular detection of prostate cancer in urine by GSTP1 hypermethylation. Clin Cancer Res 2001;7:2727-30
   PubMed Web of Science ®Google Scholar
• Laxman B, Tomlins SA, Mehra R, et al. Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer. Neoplasia 2006;8:885-8
   PubMed Web of Science ®Google Scholar
• Groskopf J, Aubin SM, Deras IL, et al. APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer. Clin Chem 2006;52:1089-95
   PubMed Web of Science ®Google Scholar
• Fliss MS, Usadel H, Caballero OL, et al. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 2000;287:2017-9
   PubMed Web of Science ®Google Scholar
• Andrews RM, Kubacka I, Chinnery PF, et al. Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet 1999;23:147
   PubMed Web of Science ®Google Scholar
• Wallace DC. A mitochondrial paradigm of metabolic and degenerative diseases, ageing, and cancer: a dawn for evolutionary medicine. Ann Rev Genet 2005;39:359-407
   PubMed Web of Science ®Google Scholar
• Clayton DA, Vinograd J. Complex mitochondrial DNA in leukemic and normal human myeloid cells. Proc Natl Acad Sci USA 1969;62:1077-84
   PubMed Web of Science ®Google Scholar
• Horton TM, Petros JA, Heddi A, et al. Novel mitochondrial DNA deletion found in a renal cell carcinoma. Genes Chromosomes Cancer 1996;15:95-101
   PubMed Web of Science ®Google Scholar
• Dakubo GD, Jakupciak JP, Birch-Machin MA, et al. Clinical implications and utility of field cancerization. Cancer Cell Int 2007;7:2
   PubMed Web of Science ®Google Scholar
• Jiang WW, Masayesva B, Zahurak M, et al. Increased mitochondrial DNA content in saliva associated with head and neck cancer. Clin Cancer Res 2005;11:2486-91
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu VW, Xue WC, et al. The increase of mitochondrial DNA content in endometrial adenocarcinoma cells: a quantitative study using laser-captured microdissected tissues. Gynecol Oncol 2005;98:104-10
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu VW, Xue WC, et al. Association of decreased mitochondrial DNA content with ovarian cancer progression. Br J Cancer 2006;95:1087-91
   PubMed Web of Science ®Google Scholar
• Tseng LM, Yin PH, Chi CW, et al. Mitochondrial DNA mutations and mitochondrial DNA depletion in breast cancer. Genes Chromosomes Cancer 2006;45:629-38
   PubMed Web of Science ®Google Scholar
• Lievre A, Chapusot C, Bouvier AM, et al. Clinical value of mitochondrial mutations in colorectal cancer. J Clin Oncol 2005;23:3517-25
   PubMed Web of Science ®Google Scholar
• Mehra N, Penning M, Maas J, et al. Circulating mitochondrial nucleic acids have prognostic value for survival in patients with advanced prostate cancer. Clin Cancer Res 2007;13:421-6
   PubMed Web of Science ®Google Scholar
• Naito A, Carcel-Trullols J, Xie CH, et al. Induction of acquired resistance to antiestrogen by reversible mitochondrial DNA depletion in breast cancer cell line. Int J Cancer 2008;122(7):1506-11
   PubMed Web of Science ®Google Scholar
• Higuchi M, Kudo T, Suzuki S, et al. Mitochondrial DNA determines androgen dependence in prostate cancer cell lines. Oncogene 2006;25:1437-45
   PubMed Web of Science ®Google Scholar
• Xie CH, Naito A, Mizumachi T, et al. Mitochondrial regulation of cancer associated nuclear DNA methylation. Biochem Biophys Res Commun 2007;364:656-61
   PubMed Web of Science ®Google Scholar
• Petros JA, Baumann AK, Ruiz-Pesini E, et al. mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci USA 2005;102:719-24
   PubMed Web of Science ®Google Scholar
• Polyak K, Li Y, Zhu H, et al. Somatic mutations of the mitochondrial genome in human colorectal tumors. Nat Genet 1998;20:291-3
   PubMed Web of Science ®Google Scholar
• Salas A, Yao YG, Macaulay V, et al. A critical reassessment of the role of mitochondria in tumorigenesis. PLoS Med 2005;2:e296
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Fujimoto A, Hoon DS. Detection of mitochondrial DNA alterations in plasma of malignant melanoma patients. Ann NY Acad Sci 2004;1022:50-4
   PubMed Web of Science ®Google Scholar
• Hibi K, Nakayama H, Yamazaki T, et al. Detection of mitochondrial DNA alterations in primary tumors and corresponding serum of colorectal cancer patients. Int J Cancer 2001;94:429-31
   PubMed Web of Science ®Google Scholar
• Hibi K, Robinson CR, Booker S, et al. Molecular detection of genetic alterations in the serum of colorectal cancer patients. Cancer Res 1998;58:1405-7
   PubMed Web of Science ®Google Scholar
• Nomoto S, Yamashita K, Koshikawa K, et al. Mitochondrial D-loop mutations as clonal markers in multicentric hepatocellular carcinoma and plasma. Clin Cancer Res 2002;8:481-7
   PubMed Web of Science ®Google Scholar
• Okochi O, Hibi K, Uemura T, et al. Detection of mitochondrial DNA alterations in the serum of hepatocellular carcinoma patients. Clin Cancer Res 2002;8:2875-8
   PubMed Web of Science ®Google Scholar
• Masayesva BG, Mambo E, Taylor RJ, et al. Mitochondrial DNA content increase in response to cigarette smoking. Cancer Epidemiol Biomarkers Prev 2006;15:19-24
   PubMed Web of Science ®Google Scholar
• Zhou S, Kachhap S, Sun W, et al. Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neck. Proc Natl Acad Sci USA 2007;104:7540-5
   PubMed Web of Science ®Google Scholar
• Mithani SK, Smith IM, Zhou S, et al. Mitochondrial resequencing arrays detect tumor-specific mutations in salivary rinses of patients with head and neck cancer. Clin Cancer Res 2007;13:7335-40
   PubMed Web of Science ®Google Scholar
• Kim MM, Clinger JD, Masayesva BG, et al. Mitochondrial DNA quantity increases with histopathologic grade in premalignant and malignant head and neck lesions. Clin Cancer Res 2004;10:8512-5
   PubMed Web of Science ®Google Scholar
• Jiang WW, Rosenbaum E, Mambo E, et al. Decreased mitochondrial DNA content in post-treatment salivary rinses from head and neck cancer patients. Clin Cancer Res 2006;12:1564-9
   PubMed Web of Science ®Google Scholar
• American Cancer Society. Cancer Facts and Figures 2007. Atlanta: American Cancer Society; 2007
   Google Scholar
• Ballinger SW, Bouder TG, Davis GS, et al. Mitochondrial genome damage associated with cigarette smoking. Cancer Res 1996;56:5692-7
   PubMed Web of Science ®Google Scholar
• Isaacs C, Cavalli LR, Cohen Y, et al. Detection of LOH and mitochondrial DNA alterations in ductal lavage and nipple aspirate fluids from high-risk patients. Breast Cancer Res Treat 2004;84:99-105
   PubMed Web of Science ®Google Scholar
• Zhu W, Qin W, Bradley P, et al. Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid. Carcinogenesis 2005;26:145-52
   PubMed Web of Science ®Google Scholar
• Maitra A, Cohen Y, Gillespie SE, et al. The Human MitoChip: a high-throughput sequencing microarray for mitochondrial mutation detection. Genome Res 2004;14:812-9
   PubMed Web of Science ®Google Scholar
• Jeronimo C, Nomoto S, Caballero OL, et al. Mitochondrial mutations in early stage prostate cancer and bodily fluids. Oncogene 2001;20:5195-8
   PubMed Web of Science ®Google Scholar
• Parr RL, Dakubo GD, Crandall KA, et al. Somatic mitochondrial DNA mutations in prostate cancer and normal appearing adjacent glands in comparison to age-matched prostate samples without malignant histology. J Mol Diagn 2006;8:312-9
   PubMed Web of Science ®Google Scholar
• Wong LJ, Lueth M, Li XN, et al. Detection of mitochondrial DNA mutations in the tumor and cerebrospinal fluid of medulloblastoma patients. Cancer Res 2003;63:3866-71
   PubMed Web of Science ®Google Scholar
• Kirches E, Krause G, Weis S, et al. Comparison between mitochondrial DNA sequences in low grade astrocytomas and corresponding blood samples. Mol Pathol 2002;55:204-6
   PubMedGoogle Scholar
• Kirches E, Krause G, Warich-Kirches M, et al. High frequency of mitochondrial DNA mutations in glioblastoma multiforme identified by direct sequence comparison to blood samples. Int J Cancer 2001;93:534-8
   PubMed Web of Science ®Google Scholar
• Zhou S, Kassauei K, Cutler DJ, et al. An oligonucleotide microarray for high-throughput sequencing of the mitochondrial genome. J Mol Diagn 2006;8:476-82
   PubMed Web of Science ®Google Scholar
• Conley YP, Brockway H, Beatty M, et al. Qualitative and quantitative detection of mitochondrial heteroplasmy in cerebrospinal fluid using denaturing high-performance liquid chromatography. Brain Res Brain Res Protoc 2003;12:99-103
   PubMedGoogle Scholar
• Meierhofer D, Mayr JA, Ebner S, et al. Rapid screening of the entire mitochondrial DNA for low-level heteroplasmic mutations. Mitochondrion 2005;5:282-96
   PubMed Web of Science ®Google Scholar
• Ronaghi M, Uhlen M, Nyren P. A sequencing method based on real-time pyrophosphate. Science 1998;281:363-5
   PubMed Web of Science ®Google Scholar
• Andreasson H, Asp A, Alderborn A, et al. Mitochondrial sequence analysis for forensic identification using pyrosequencing technology. Biotechniques 2002;32:124-6
   PubMed Web of Science ®Google Scholar
• White HE, Durston VJ, Seller A, et al. Accurate detection and quantitation of heteroplasmic mitochondrial point mutations by pyrosequencing. Genet Test 2005;9:190-9
   PubMedGoogle Scholar
• Parfait B, Rustin P, Munnich A, et al. Co-amplification of nuclear pseudogenes and assessment of heteroplasmy of mitochondrial DNA mutations. Biochem Biophys Res Commun 1998;247:57-9
   PubMed Web of Science ®Google Scholar
• Parr RL, Maki J, Reguly B, et al. The pseudo-mitochondrial genome influences mistakes in heteroplasmy interpretation. BMC Genomics 2006;7:185
   PubMed Web of Science ®Google Scholar
• Fahy E, Nazarbaghi R, Zomorrodi M, et al. Multiplex fluorescence-based primer extension method for quantitative mutation analysis of mitochondrial DNA and its diagnostic application for Alzheimer's disease. Nucleic Acids Res 1997;25:3102-9
   PubMed Web of Science ®Google Scholar
• Davis RE, Miller S, Herrnstadt C, et al. Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer's disease. Proc Natl Acad Sci USA 1997;94:4526-31
   PubMed Web of Science ®Google Scholar
• Folkman J. Can mosaic tumor vessels facilitate molecular diagnosis of cancer? Proc Natl Acad Sci USA 2001;98:398-400
   PubMed Web of Science ®Google Scholar
• Chen X, Bonnefoi H, Diebold-Berger S, et al. Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer. Clin Cancer Res 1999;5:2297-303
   PubMed Web of Science ®Google Scholar
• Sorenson GD, Porter DM, Barth RJ, et al. Detection of mutated KRAS2 sequences in plasma from patients with pancreatic carcinoma in comparison with the CA19-9 assay. J Int Soc Oncodev Biol Med 1977;18:66
   Web of Science ®Google Scholar